Catalent provides contract development and manufacturing services (CDMO) for the pharmaceutical and biotech industries, offering solutions for drug development, delivery, and supply chain management.

Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.

COM:CATALENT

Catalent

Last Close

59.66

22/11 21:00

Market Cap

11.07B

Beta: -

Volume Today

4.87M

Avg: -

locale

market

industry

website

ipo date

peer of

investor of

competitor of

Metrics